Epidemiological Multicohort Study of Latent COVID-19 Infections
NCT ID: NCT04695678
Last Updated: 2022-04-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
1462 participants
OBSERVATIONAL
2020-07-01
2021-12-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Course and Treatment of COVID-19 Inpatients in Hospital
NCT04527497
SARS-CoV-2 Seroprevalence Among Nursing Home Staff and Residents (COVID-19)
NCT04738695
Health Professional Exposure Assessment to Covid-19
NCT04429724
Testing for COVID-19 Infection in Asymptomatic Persons
NCT04345510
Screening for COVID-19 and Monitoring of Serological Responses to SARS-CoV-2 in Healthcare Workers
NCT04370119
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
1. Prevalence of latent COVID-19 infections at one point in time among residents and staff of old people's and nursing homes in Solingen.
2. Prevalence of latent COVID-19 infections over a period of 6 months among staff of a single nursing home (=subgroup)
3. Analysis of transmission pathways of the virus in a nursing home
4. Analysis of the effectiveness of hygiene measures taken
5. Analysis of risk factors (previous illnesses, medication, etc.)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
residents and staff of all nursing homes in Solingen
each study participant receives a single nasal/pharyngeal swab
COVID-19 nasal/pharyngeal swab
each study participant receives a nasal/pharyngeal swab
staff of one single nursing home in Solingen
each study participant receives a weekly nasal/pharyngeal swab for six months
COVID-19 nasal/pharyngeal swab
each study participant receives a nasal/pharyngeal swab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
COVID-19 nasal/pharyngeal swab
each study participant receives a nasal/pharyngeal swab
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Wissenschaftliches Institut Bethanien e.V
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Winfried Randerath
Role: PRINCIPAL_INVESTIGATOR
Krankenhaus Bethanien Solingen
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Institut für Pneumologie an der Universität zu Köln / Wissenschaftliches Institut Bethanien für Pneumologie e.V.
Solingen, North Rhine-Westphalia, Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
WI-2020179
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.